[et_pb_section fb_built=”1″ admin_label=”Executive Management Section” _builder_version=”4.16″ collapsed=”on” global_colors_info=”{}”][et_pb_row custom_padding_last_edited=”on|phone” _builder_version=”4.16″ custom_margin_tablet=”0px||0px|” custom_margin_phone=”” custom_margin_last_edited=”on|phone” custom_padding_tablet=”0px||0px|” custom_padding_phone=”” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ background_position=”top_left” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.16″ text_orientation=”center” module_alignment=”center” border_style=”solid” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ custom_padding_last_edited=”on|phone” _builder_version=”4.16″ custom_margin_tablet=”0px|||” custom_margin_phone=”” custom_margin_last_edited=”on|phone” custom_padding_tablet=”0px|||” custom_padding_phone=”” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ background_position=”top_left” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”Dr Brad Walsh” position=”CEO” image_url=”https:\/\/minomic.com\/wp-content\/uploads\/2017\/07\/brad_walsh.jpg” admin_label=”Dr. Brad Walsh” _builder_version=”4.16″ border_style=”solid” global_colors_info=”{}”]<\/p>\n
Founded Minomic raising over A$27 million to commercialize its first major product, MiCheck, as well as developing a pipeline of new diagnostics for other cancers.<\/span><\/p>\n He has a PhD in protein chemistry and has led research groups in government agencies, universities and hospitals. <\/span><\/p>\n Dr Walsh was a key part of the establishment of a major national research facility before forming Minomic in 2007. He has a long history of commercialization and his products are being sold by major corporations, such as Bio-Rad Laboratories.<\/span><\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ background_position=”top_left” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”David Burdis” position=”CFO \/ Company Secretary” image_url=”https:\/\/minomic.com\/wp-content\/uploads\/2017\/06\/david_burdis.jpg” admin_label=”David Burdis” _builder_version=”4.16″ border_style=”solid” global_colors_info=”{}”]<\/p>\n Is a seasoned financial professional having worked in the chemical, telecommunications, and financial services industries. <\/span><\/p>\n He has held various senior\/board positions, for both listed and unlisted companies, in Australia, the UK and Hong Kong, including Swire Blanch Limited and OAMPS Limited. <\/span><\/p>\n His extensive consulting background includes provision of services to industry and government as well as expert witness evidence.<\/span><\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ background_position=”top_left” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”Dr Douglas Campbell” position=”Head of Research and Development” image_url=”https:\/\/minomic.com\/wp-content\/uploads\/2017\/07\/Dr-Douglas-Campbell.jpg” admin_label=”Dr. Douglas Campbell” _builder_version=”4.16″ border_style=”solid” global_colors_info=”{}”]<\/p>\n Leads Minomic\u2019s scientific team. He has been instrumental in building Minomic\u2019s intellectual property estate and designing all the clinical trials. <\/span><\/p>\n Dr Campbell has nearly 20 years of experience in biomedical research with a particular focus on oncology. Prior to Minomic he was involved in the development of a novel antibody (MDX-1097) from pre-clinical to Phase 2 clinical trials.<\/span><\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_team_member name=”Dr Yanling Lu” position=”Head of CMC (Chemistry, Manufacturing and Control) ” image_url=”https:\/\/minomic.com\/wp-content\/uploads\/2020\/03\/Yanling-Lu.jpg” admin_label=”Dr. Brad Walsh” _builder_version=”4.16″ border_style=”solid” global_colors_info=”{}”]<\/p>\n Over 15 years’ experience in the biotech and medtech industries specialising in product development and assay validation. <\/span><\/p>\n In 2016 Dr Lu moved to Clinical Genomics, leading the analytical validation of CG\u2019s new product InSureOne\u2122 which was a key to its successful FDA 510(k) approval. <\/span><\/p>\n She was involved in the technology transfer of CG\u2019s diagnostic test into their CLIA laboratory at Bridgewater (NJ). She is also conversant with regulatory guidelines (FDA, EMA, ICH, TGA and CLSI etc)<\/span>.<\/span><\/p>\n [\/et_pb_team_member][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ custom_padding_last_edited=”on|phone” _builder_version=”4.21.0″ custom_margin_tablet=”0px|||” custom_margin_phone=”” custom_margin_last_edited=”on|phone” custom_padding_tablet=”0px|||” custom_padding_phone=”” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][et_pb_column type=”1_3″ _builder_version=”4.16″ background_position=”top_left” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”Megan Henken ” position=”US Commercialisation Lead ” image_url=”https:\/\/minomic.com\/wp-content\/uploads\/2021\/02\/meganhenken.jpeg” admin_label=”David Burdis” _builder_version=”4.21.0″ border_style=”solid” global_colors_info=”{}”]<\/p>\n Is a global marketing and sales strategist with over 15 years of healthcare experience, spanning clinical diagnostics, LDTs, point-of-care medical devices, e-health, and distribution. <\/span><\/p>\n At Focus Diagnostics, a\u00a0subsidiary of Quest Diagnostics, launched a molecular platform along with 3 FDA cleared assays, 8 CE kits and 20 ASRs for the development of LDTs. She established a consulting firm in 2014, collaborating with emerging technologies to establish strong clinical relationships to drive early adoption and product roadmaps for commercialization.<\/span><\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_team_member name=”Lorne Havenhill” position=”US Sales Executive” image_url=”https:\/\/minomic.com\/wp-content\/uploads\/2023\/05\/Lorne-Havenhill-1.jpg” admin_label=”David Burdis” _builder_version=”4.21.0″ border_style=”solid” global_colors_info=”{}”]<\/p>\n 30+ years of pharmaceutical medical\/lab leadership experience after beginning his career in academics and biomedical research. <\/span><\/p>\n Lorne’s executive background includes positions as VP & Director of Operations and Sales, National Sales Director, Regional & Area Director, Director of Key Customer Development and other leadership roles.<\/span><\/p>\n Lorne has been involved in multiple companies, field force, and product buildouts and launches. His interests also include corporate leadership and development where he holds certification in multiple leadership development platforms.<\/span><\/span><\/p>\n [\/et_pb_team_member][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ background_position=”top_left” custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_team_member name=”Carl Stubbings” position=”Chief Commercialisation Officer” image_url=”https:\/\/minomic.com\/wp-content\/uploads\/2019\/03\/Carl-Stubbings.jpg” admin_label=”Dr. Douglas Campbell” _builder_version=”4.17.6″ border_style=”solid” global_colors_info=”{}”]<\/p>\n Carl is an experienced senior leader in the biotechnology and diagnostics industry.<\/span><\/p>\n He has considerable experience commercialising diagnostic products, both locally and globally. <\/span><\/p>\n Carl has Bachelor of Applied Science (Medical Technology) from Queensland University of Technology.<\/span><\/p>\n [\/et_pb_team_member][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.19.5″ _module_preset=”default” background_color=”#75C044″ custom_margin=”||-2px||false|false” custom_padding=”0px||0px||false|false” global_module=”27400″ global_colors_info=”{}”][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.19.5″ _module_preset=”default” custom_margin=”||||false|false” custom_padding=”0px||0px||false|false” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.19.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.20.2″ _module_preset=”default” text_font=”|600||on|||||” text_text_color=”#FFFFFF” text_font_size=”12px” text_orientation=”center” custom_margin=”||||true|false” custom_padding=”||||false|false” global_colors_info=”{}”]<\/p>\n